Tweet
Phoenix, Me and Mrs. billy both hit all time record highs in our retirement stock portfolios yesterday. This potentially could be a great September.
------------billy
------------billy
-
-
Billie check your portfolios after yesterday's close ......you probably took a hair cut in both portfolios, and SEPTEMBER is not even half way through!Originally posted by billyjoe View PostComment
-
I am always searching for NEW Opportunities in the stock market, and according to one pundit NOTHING is growing as fast as the market for "Legal" marijuana! So I have run through some marijuana stocks for potential "HOT" Prospects. I will tell you about 2 tomorrow. Stay cool and have a beautiful weekend!Comment
-
-
"GREEN GOLD"
By 2020, the market for legal marijuana will top $22.8 billion. When that happens, the legal market for cannabis “could be bigger than the National Football League, which saw roughly $12 billion of revenue last year,” according to Fortune!
Investment bank Ackrell Capital predicted in March that between 2016 and 2029 the market for marijuana will reach $100 billion – 1,308% growth.
Once legalization takes hold everywhere, dozens of already established firms – in the tobacco industry… in agriculture and irrigation… in pharmaceuticals – are going to want to jump in without hesitation.
According to researchers from ArcView, a highly respected Silicon Valley cannabis market research group, there’s “a 92.8% chance” that 26 or more U.S. states – a clear majority – will allow legal cannabis in one form or another before the year is out.
On election day November 8, 2016 , tens of millions of Americans will head to the polls. Voters in many states will be given the chance to legalize or decriminalize marijuana, or at least approve it for medical uses. And while no one can say for sure how people will vote, odds are that some if not most of these states will vote “Yes.
In 2015 $215 million in venture capital flooded into the marijuana industry. This cash went towards farms and dispensaries, weed technology, and real estate… every nook and cranny of the pot business.
Folks to be honest here much of the information is based on many "IFS" and the stocks listed below are highly "SPECULATIVE", but for those willing to throw caution to the wind , put the petal to the metal and GO FOR IT, and "IF" the cards fall our way a king's ransom could be made!
First Stock Up is OGRMF . Here is information on the ORGMF
About Organigram Holdings Inc. OBRMF Chart: http://schrts.co/U6iLng 2nd Chart: http://www.barchart.com/interactive_charts/stocks/OGRMF
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.
When you look at all the mj stocks out there, I haven't found any others that were "profitable" now....lots of potential but for investors wanting a head start OGRMF is already "PRIFITABLE" and growing very rapidly.
Here is the impressive latest quarterly results for OGRMF
Organigram Delivers Strong Results Across All Metrics in Q3
Marketwired July 25, 2016Comment
MONCTON, NEW BRUNSWICK--(Marketwired - Jul 25, 2016) - Organigram Holdings Inc. (TSX VENTURE:OGI)(OGRMF) (the "Company") is pleased to report its financial results for the third quarter ending May 31st, 2016. All amounts are expressed in Canadian dollars unless stated otherwise.
Highlights from the quarter include:
27% growth in sales compared to the prior quarter
Net revenue of $8.47 per gram sold
EBITDA1 growth to $695,721 from $370,139 in the prior quarter
Summary Quarterly Results
Operating/Financial Metric Q3 2016 (May) Q2 2016 (February)
Revenue $ 1,806,849 $ 1,425,466
Grams Sold 213,270 169,215
Gross Margin 87.6 % 76.0 %
Net Income (Loss) $367,720 $55,267
EBITDA1 $ 695,721 $ 370,139
Organigram continued its positive operating momentum and generated sales of $1,806,849 which represents a 27% increase compared to the previous quarter. Grams sold for the quarter increased to 213,270, resulting in an average net revenue per gram sold of approximately $8.47.
The Company continues to focus on process and cost initiatives and is pleased to note a significant increase in plant yields and a corresponding decrease in its production costs. Organigram's cash cost per gram produced during the quarter was $1.292. These efficiencies help validate the changes the Company has made to its in-house production practices and strengthen Organigram's strategic positioning as one of the lowest cost MMPR producers in Canada.
"We are very pleased with our 3rd quarter results and as things continue to develop post quarter, we remain focused and drive our efforts to be one of Canada's lowest cost producers" states Denis Arsenault, CEO of Organigram Inc.
Subsequent to the quarter, Organigram closed its previously announced bought deal financing for net proceeds of $10,360,350, received an amendment to its MMPR license allowing for the sale of cannabis oil extracts, and submitted a request to Health Canada for an increase to Organigrams licensed sales capacity ("LSC") for its facility in Moncton, New Brunswick.
"At Organigram we are creating employment and economic growth opportunities for Atlantic Canadians, a reliable and high quality product for our customers, and value and efficiencies for our shareholders. Our low cost of production, coupled with our organic product offering, strong balance sheet, and near term growth prospects position Organigram favourably in both the existing medicinal and forthcoming recreational marketplace." says Arsenault.
2nd Stock UP is SPRWF :
Supreme SPRWF is heading to become one of the largest producers of marijuana in Canada and the world so why would this stock ever be trading lower? Anyone?
Nice Video https://twitter.com/ScottMillerCTV/s...25897247457280 MAKE SURE THE SPEAKER INDICATOR ON LOWER RIGHT DOES NOT HAVE AN X ON IT! IF IT DOES CLICK ON IT TO ACTIVATE THE SOUND!
SPRWF License to sell should arrive around November as well, there are plenty of catalysts from here on out through spring of next year as well as Expansion of the grow capacity of the facility etc. FROM the Video above "Supreme Pharmaceuticals SPRWF is expanding quickly and on a "MASSIVE" scale ." I like that!
Chart: http://schrts.co/45lzp4 2nd Chart: http://www.barchart.com/interactive_charts/stocks/SPRWFLast edited by Phoenix7; 09-11-2016, 10:15 AM.Comment
-
Louetta unfortunately MCIG has languished for years and it currently rated a 24 out of 100 with my Market Trend Signals program , and currently has a "HOLD" rating, but NO ONE can say how MCIG will fare after the election on November 8th!Originally posted by Louetta View Post
The 2 stocks I detail below both have a 100 rating with both also having a BUY rating!
I would not put any more money into MCIG, but one idea would be to sell your position in MCIG and invest the proceeds equally into SPRWF and OGRMF. It's just a suggestion , but you must do what makes you comfortable. Good Luck with any decision , and thanks for your input!Comment
-
(REPOST DUE TO PAGE CHANGE!)
"GREEN GOLD"
By 2020, the market for legal marijuana will top $22.8 billion. When that happens, the legal market for cannabis “could be bigger than the National Football League, which saw roughly $12 billion of revenue last year,” according to Fortune!
Investment bank Ackrell Capital predicted in March that between 2016 and 2029 the market for marijuana will reach $100 billion – 1,308% growth.
Once legalization takes hold everywhere, dozens of already established firms – in the tobacco industry… in agriculture and irrigation… in pharmaceuticals – are going to want to jump in without hesitation.
According to researchers from ArcView, a highly respected Silicon Valley cannabis market research group, there’s “a 92.8% chance” that 26 or more U.S. states – a clear majority – will allow legal cannabis in one form or another before the year is out.
On election day November 8, 2016 , tens of millions of Americans will head to the polls. Voters in many states will be given the chance to legalize or decriminalize marijuana, or at least approve it for medical uses. And while no one can say for sure how people will vote, odds are that some if not most of these states will vote “Yes.
In 2015 $215 million in venture capital flooded into the marijuana industry. This cash went towards farms and dispensaries, weed technology, and real estate… every nook and cranny of the pot business.
Folks to be honest here much of the information is based on many "IFS" and the stocks listed below are highly "SPECULATIVE", but for those willing to throw caution to the wind , put the petal to the metal and GO FOR IT, and "IF" the cards fall our way a king's ransom could be made!
First Stock Up is OGRMF . Here is information on the ORGMF
About Organigram Holdings Inc. OBRMF Chart: http://schrts.co/U6iLng
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.
When you look at all the mj stocks out there, I haven't found any others that were "profitable" now....lots of potential but for investors wanting a head start OGRMF is already "PROFITABLE" and growing very rapidly.
Here is the impressive latest quarterly results for OGRMF
Organigram Delivers Strong Results Across All Metrics in Q3
Marketwired July 25, 2016Comment
MONCTON, NEW BRUNSWICK--(Marketwired - Jul 25, 2016) - Organigram Holdings Inc. (TSX VENTURE:OGI)(OGRMF) (the "Company") is pleased to report its financial results for the third quarter ending May 31st, 2016. All amounts are expressed in Canadian dollars unless stated otherwise.
Highlights from the quarter include:
27% growth in sales compared to the prior quarter
Net revenue of $8.47 per gram sold
EBITDA1 growth to $695,721 from $370,139 in the prior quarter
Summary Quarterly Results
Operating/Financial Metric Q3 2016 (May) Q2 2016 (February)
Revenue $ 1,806,849 $ 1,425,466
Grams Sold 213,270 169,215
Gross Margin 87.6 % 76.0 %
Net Income (Loss) $367,720 $55,267
EBITDA1 $ 695,721 $ 370,139
Organigram continued its positive operating momentum and generated sales of $1,806,849 which represents a 27% increase compared to the previous quarter. Grams sold for the quarter increased to 213,270, resulting in an average net revenue per gram sold of approximately $8.47.
The Company continues to focus on process and cost initiatives and is pleased to note a significant increase in plant yields and a corresponding decrease in its production costs. Organigram's cash cost per gram produced during the quarter was $1.292. These efficiencies help validate the changes the Company has made to its in-house production practices and strengthen Organigram's strategic positioning as one of the lowest cost MMPR producers in Canada.
"We are very pleased with our 3rd quarter results and as things continue to develop post quarter, we remain focused and drive our efforts to be one of Canada's lowest cost producers" states Denis Arsenault, CEO of Organigram Inc.
Subsequent to the quarter, Organigram closed its previously announced bought deal financing for net proceeds of $10,360,350, received an amendment to its MMPR license allowing for the sale of cannabis oil extracts, and submitted a request to Health Canada for an increase to Organigrams licensed sales capacity ("LSC") for its facility in Moncton, New Brunswick.
"At Organigram we are creating employment and economic growth opportunities for Atlantic Canadians, a reliable and high quality product for our customers, and value and efficiencies for our shareholders. Our low cost of production, coupled with our organic product offering, strong balance sheet, and near term growth prospects position Organigram favourably in both the existing medicinal and forthcoming recreational marketplace." says Arsenault.
2nd Stock UP is SPRWF :
Supreme SPRWF is heading to become one of the largest producers of marijuana in Canada and the world so why would this stock ever be trading lower? Anyone?
Nice Video
Supreme Pharmaceuticals Inc. Folks this video on You Tube is "IMPRESSIVE" https://uk.video.search.yahoo.com/se...94&action=view MAKE SURE THE SPEAKER INDICATOR ON LOWER RIGHT DOES NOT HAVE AN X ON IT! IF IT DOES CLICK ON IT TO ACTIVATE THE SOUND!
SPRWF License to sell should arrive around November as well, there are plenty of catalysts from here on out through spring of next year as well as Expansion of the grow capacity of the facility etc. FROM the Video above "Supreme Pharmaceuticals SPRWF is expanding quickly and on a "MASSIVE" scale ." I like that!
Chart: http://schrts.co/45lzp4
FOLKS I CHANGED FACE BOOK TO A YOU TUBE VIDEO MUCH BETTER! DON'T MISS THIS VIDEO!! https://uk.video.search.yahoo.com/se...94&action=view
MORNINGSTAR CHART OF ORGMF . Simply click on comparison and add the other stock SPRWF http://performance.morningstar.com/s...&culture=en_USLast edited by Phoenix7; 09-11-2016, 03:43 PM.Comment
-
Interesting Pharmaceutical RETA Just watching for now! Chart: http://schrts.co/5aBNFT 2nd Chart: http://finviz.com/quote.ashx?t=RETA&ty=c&ta=1&p=d
Reata Pharmaceuticals (RETA) , a clinical stage biopharmaceutical company, focuses on identifying, developing and commercializing product candidates that modulate the activity of key regulatory proteins involved in the biology of mitochondrial function, oxidative stress and inflammation to address the unmet medical needs of patients with various serious or life-threatening diseases. This stock closed up 18.7% to $24.99 in Wednesday's trading session.
From a technical perspective, Reata Pharmaceuticals gapped-up sharply higher on Wednesday with strong upside volume flows. This high-volume explosion to the upside is now quickly pushing shares of Reata Pharmaceuticals within range of triggering a major breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out Wednesday's intraday high of $25.95 a share and then once it clears its all-time high of $26.90 a share with high volume.
Traders should now look for long-biased trades in Reata Pharmaceuticals as long as it's trending above Wednesday's intraday low of $22.45 a share or above its previous breakout levels at $20.62 to $20.55 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 109,441 shares. If that breakout triggers soon, then this stock will set up to enter new all-time-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $30 to $35, or even $40 a share.Last edited by Phoenix7; 09-14-2016, 08:33 AM.Comment
-
-
Folks according to an article in the L.A. Times California voters are likely to approve the legalization of Marijuana which is on their state ballot in November! Watch the Marijuana stocks go KABOOM!Originally posted by Phoenix7 View PostComment
-
Comment
-
-
Folks may have found someone who knows something about options The Stock is CIEN and the suggested Option is to BUY The October 21 , 2016 21 CALLS at about $1.15 .........let's see how good my mentor is.
CIEN Chart: http://schrts.co/jPgkrh 2nd Chart: http://finviz.com/quote.ashx?t=CIEN&ty=c&ta=1&p=dLast edited by Phoenix7; 09-15-2016, 08:31 PM.Comment
-
Folks looking into putting together 5 Marijuana stocks into a portfolio called the , "Marijuana Green Gold Portfolio" The five stocks will be volatile , but financial gains could be huge, if the cards fall our way. As usual NO guarantees are given that you will make money with the portfolio and you could lose money!
On another note the Safe Haven Gold Portfolio is currently up 7.79% since its inception!
See you Sunday with the New Marijuana Green Gold Portfolio!Comment
-
Originally posted by Phoenix7 View Post
Good. I'm going to be very interested in this one. (Marijuana, not gold.)Comment
Comment